FindTrial
Sign In

Precision Classification and Novel Target Research in Lymphoma

Establishment of Precision Molecular Subtyping and Novel Target Discovery in Lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113557
Enrollment
Unknown
Registered
2025-12-01
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphomas

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed diagnosis of lymphoma. 2.Complete clinical case data, including diagnostic imaging at the time of diagnosis. 3.Complete follow-up information.

Exclusion criteria

Exclusion criteria: 1.Patients lost to follow-up or without clear pathological diagnostic evidence. 2.Patients with unclear efficacy evaluation.

Design outcomes

Primary

MeasureTime frame
Complete remission;Progression-free survival,;Overall survival;—

Countries

China

Contacts

Public ContactXudong Zhang

The First Affiliated Hospital of Zhengzhou University

fcczhangxd@zzu.edu.cn+86 371 66279567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026